Labels
Breast Cancers
(147)
Genitourinary Cancers
(73)
Lung Cancers
(73)
Gastrointestinal Cancers
(67)
Gynecological Cancers
(56)
Head and Neck Cancers
(50)
Cutaneous Cancers
(21)
Central Nervous System Cancers
(11)
Monday 24 March 2014
FDA has questions about accuracy of 2 colon cancer screening tools
The Food and Drug Administration is weighing the benefits and risks of two experimental colon cancer screening tests which use DNA from a patient's stool to detect dangerous tumors and growths. FDA scientists have questions about the accuracy and the potential real-world impact of the kits from Epigenomics and Exact Sciences, according to briefing documents posted online. The agency released its reviews of the tests ahead of a two-day meeting. Read more here.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment